Anaconda Pharma is a biopharmaceutical company focusing on the development of treatments for infections by human papillomavirus (HPV).
Anaconda Pharma has raised €2.9M across 1 funding round from 1 investor, most recently a round in Jul 2010. Based in Paris, France; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2010-07-01 | Other | €2.9M |
| Aurinvest |
| View deal → |
